Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer?

BMC Cancer

Geertruida H De Bock³  Theo Wiggers⁴  Peter C Baas⁵  Michael Schaapveld²  Liesbeth Jansen⁴  Wenli Lu¹ 

[1]Department of Epidemiology, Tianjin Medical University Cancer Institute and Hospital, China

[2]Comprehensive Cancer Centre North-Netherlands, The Netherlands

[3]Department of Epidemiology, University Medical Center Groningen, University of Groningen, The Netherlands

[4]Department of Surgery, University Medical Center Groningen, University of Groningen, The Netherlands

[5]Department of Surgery, Martiniziekenhuis, The Netherlands

关键词: Mammography;    Follow-up;    Utilization;    Breast neoplasm;   

Others  :  1080856
DOI  :  10.1186/1471-2407-11-279

 received in 2010-11-27, accepted in 2011-06-28,  发布年份 2011

【 摘 要 】

Background

After primary treatment for breast cancer, patients are recommended to use hospital follow-up care routinely. Long-term data on the utilization of this follow-up care are relatively rare.

Methods

Information regarding the utilization of routine hospital follow-up care was retrieved from hospital documents of 662 patients treated for breast cancer. Utilization of hospital follow-up care was defined as the use of follow-up care according to the guidelines in that period of time. Determinants of hospital follow up care were evaluated with multivariate analysis by generalized estimating equations (GEE).

Results

The median follow-up time was 9.0 (0.3-18.1) years. At fifth and tenth year after diagnosis, 16.1% and 33.5% of the patients had less follow-up visits than recommended in the national guideline, and 33.1% and 40.4% had less frequent mammography than recommended. Less frequent mammography was found in older patients (age > 70; OR: 2.10; 95%CI: 1.62-2.74), patients with comorbidity (OR: 1.26; 95%CI: 1.05-1.52) and patients using hormonal therapy (OR: 1.51; 95%CI: 1.01-2.25).

Conclusions

Most patients with a history of breast cancer use hospital follow-up care according to the guidelines. In older patients, patients with comorbidity and patients receiving hormonal therapy yearly mammography is performed much less than recommended.

【 授权许可】

   
2011 Lu et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW: Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008, 44:1345-89.
• [2]Louwman WJ, Voogd AC, van Dijck JA, Nieuwenhuijzen GA, Ribot J, Pruijt JF, Coebergh JW: On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control 2008, 19:97-106.
• [3]Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, Tavilla A, Santaquilani M, Sant M: Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009, 45:1042-66.
• [4]Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-41.
• [5]De Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ: Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol 2004, 22:4010-8.
• [6]Lu WL, Jansen L, Post WJ, Bonnema J, van d, V, de Bock GH: Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 2009, 114:403-12.
• [7]Nord C, Mykletun A, Thorsen L, Bjoro T, Fossa SD: Self-reported health and use of health care services in long-term cancer survivors. Int J Cancer 2005, 114:307-16.
• [8]van de Poll-Franse LV, Mols F, Vingerhoets AJ, Voogd AC, Roumen RM, Coebergh JW: Increased health care utilisation among 10-year breast cancer survivors. Support Care Cancer 2006, 14:436-43.
• [9]Cooper GS, Johnson CC, Lamerato L, Poisson LM, Schultz L, Simpkins J, Wells K, Yood MU, Chase G, Nathanson SD, Lafata JE: Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications? Med Care 2006, 44:590-4.
• [10]Elston Lafata J, Simpkins J, Schultz L, Chase GA, Johnson CC, Yood MU, Lamerato L, Nathanson D, Cooper G: Routine surveillance care after cancer treatment with curative intent. Med Care 2005, 43:592-9.
• [11]Peuckmann V, Ekholm O, Sjogren P, Rasmussen NK, Christiansen P, Moller S, Groenvold M: Health care utilisation and characteristics of long-term breast cancer survivors: nationwide survey in Denmark. Eur J Cancer 2009, 45:625-33.
• [12]Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-83.
• [13]Janssen-Heijnen MLG, Maas HAAM, Houtermana S, Lemmensa VEEP, Rutten HJT, Coebergh JWW: Comorbidity in older surgical cancer patients: Influence on patient care and outcome. Eur J Cancer 2007, 43:2179-93.
• [14]Schapira MM, McAuliffe TL, Nattinger AB: Underutilization of mammography in older breast cancer survivors. Med Care 2000, 38:281-9.
• [15]Rojas MP, Telaro E, Russo A, Moschetti I, Coe L, Fossati R, Palli D, del Roselli TM, Liberati A: Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 2005, (1):CD001768.
• [16]Doubeni CA, Field TS, Ulcickas Yood M, Rolnick SJ, Quessenberry CP, Fouayzi H, Gurwitz JH, Wei F: Patterns and predictors of mammography utilization among breast cancer survivors. Cancer 2006, 106:2482-8.
• [17]Field TS, Doubeni C, Fox MP, Buist DS, Wei F, Geiger AM, Quinn VP, Lash TL, Prout MN, Yood MU, Frost FJ, Silliman RA: Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med 2008, 23:158-63.
• [18]Grunfeld E, Dhesy-Thind S, Levine M: Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 2005, 172:1319-20.
• [19]ESMO: ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer. Ann Oncol 2007, 12:1047-8.
• [20]Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, Halberg F, Somerfield MR, Davidson NE: American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 2006, 24:5091-7.
• [21]Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, Verma S, Dent S, Sawka C, Pritchard KI, Ginsburg D, Wood M, Whelan T: Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 2006, 24:848-55.
• [22]Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ: Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol 2006, 24:85-94.
• [23]Andersen MR, Urban N: The use of mammography by survivors of breast cancer. Am J Public Health 1998, 88:1713-4.